D Martin

TL;DR: It was possible using the described technique to retrieve intestine, pancreas, and liver allografts safely from the same donor and to transplant these organs to different recipients.

TL;DR: The results confirm the claim that a new era has dawned for SBTx, such that, with continued progress, it can potentially become an alternative to HPN for the management of permanent intestinal failure, rather than a last-chance treatment for “TPN failure.”

TL;DR: Results validate the clinical utility of the Cylex Immune Cell Function Assay as an objective tool for assessing immune function and can identify those patients who are candidates for minimization of immunosuppressant therapy, manage the timing and rate of immunological weaning and be forewarned of increased patient risk.